Knee osteoarthritis (OA) is a chronic degenerative joint disease affecting the synovial knee joint, leading to pain, stiffness, swelling, and reduced mobility. It is one of the most common forms of arthritis and a leading cause of disability worldwide. The condition arises due to the gradual breakdown of cartilage, which cushions the ends of bones, leading to joint space narrowing, osteophyte formation, and inflammation.
The prevalence of knee OA increases with age, affecting about 3.8% of the global population, with higher rates in those over 60 years. In Australia, over 2.1 million people are estimated to have osteoarthritis, and knee OA accounts for a significant proportion of these cases. Women are more frequently affected than men, and the condition is more common in individuals who are overweight or obese.
Knee OA has a substantial impact on quality of life. It can impair walking, climbing stairs, and performing daily activities such as standing from a seated position, getting in and out of vehicles, and engaging in work or leisure. The resulting inactivity can contribute to mental health issues, including anxiety and depression.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreFrom 1 Nov 2025, the Australian government is making important changes with the Bulk Billing Practice Incentive Program (BBPIP). This FastTrack is a concise summary of how to make the most of the BBPIP, from registration, eligibility considerations, and a step-by-step approach to preparing your practice for the changes.
Two of the four core palliative care medicines are clonazepam and haloperidol, used respectively to manage anxiety and emesis in end-of-life patients. This FastTrack highlights the role of the GP in treating these two common symptoms, focusing on pharmacological strategies. 30mins each of RP and EA CPD available with the quiz.
Iron deficiency is the most common nutritional disorder around the world, affecting a disproportionate number of women. This FastTrack provides a concise summary of iron replacement in pre-menopausal women, with specific attention to menstruation and pregnancy-related iron deficiency. 30mins each of RP and EA CPD available with the quiz.